Abstract:New drug development is an extremely time-consuming and high-risk process. [1]It has been widely valued by the biomedical industry to fully explore the new uses of existing drugs and reorientate them. [2]How to find drug disease with potential therapeutic relationship from a large number of unproven relationship pairs is the research focus of drug reorientation. With the help of machine learning model, we can improve the enrichment degree of potential drug disease relationship pairs, and reduce the false positive rate of prediction. In the past few years, a series of graph based convolutional network models have been developed to calculate the information latent feature representation of nodes and links. Researchers at home and abroad have done a lot of research on network embedding technology based on biomedical data, and have achieved a series of important research results. Among them, the research methods used can be divided into two categories: one is the traditional machine learning algorithm based on artificial feature extraction, the other is the method based on deep learning. For example, kipf and welling [3]proposed a new graph convolution network (GCN) with parts of existing models, DeepDR [4] and DTINet [5] based on node characteristics and their connections, which can be used for node classification. Aiming at the problem of imbalance of drug information data samples, the invention provides a drug relocation method based on deep learning multi-source heterogeneous network. In order to avoid the limitations of traditional feature extraction methods, such as highly dependent on the experience and knowledge of medical staff, strong subjectivity, consuming a lot of time and energy to complete, and extracting high-quality features with distinguishing features often exists In this paper, with the help of graph convolution encoder model and variational auto encoder neural network, we can automatically learn the characteristics of multi-source and heterogeneous drug low-dimensional network, and complete the drug relocation of drug disease association prediction.

Drug repositioning with adaptive graph convolutional networks

Drug Repositioning by Collaborative Learning Based on Graph Convolutional Inductive Network

Drug repositioning based on the heterogeneous information fusion graph convolutional network

DRGCL: Drug Repositioning Via Semantic-enriched Graph Contrastive Learning.

Drug repositioning based on weighted local information augmented graph neural network

A Novel Graph Representation Learning Model for Drug Repositioning Using Graph Transition Probability Matrix over Heterogenous Information Networks.

Knowledge Graph Convolutional Network with Heuristic Search for Drug Repositioning

deepDR: a network-based deep learning approach to in silico drug repositioning

Enhancing Drug Repositioning through Local Interactive Learning with Bilinear Attention Networks

A geometric deep learning framework for drug repositioning over heterogeneous information networks

Attention Transfer in Heterogeneous Networks Fusion for Drug Repositioning

Drug Repositioning by Multi-Aspect Heterogeneous Graph Contrastive Learning and Positive-Fusion Negative Sampling Strategy

SADR: Self-supervised Graph Learning with Adaptive Denoising for Drug Repositioning

A Fused Deep Learning Approach to Transform Novel Drug Repositioning

Regulation-aware graph learning for drug repositioning over heterogeneous biological network

Drug Repositioning Method Based on Deep Neural Network

Drug Repositioning Based on the Enhanced Message Passing and Hypergraph Convolutional Networks

REDDA: Integrating multiple biological relations to heterogeneous graph neural network for drug-disease association prediction

Relation-aware Heterogeneous Graph Transformer Based Drug Repurposing

Drug Repurposing Therapeutics Prediction using Hierarchical Graph Neural Network.

A Drug Information Embedding Method Based on Graph Convolution Neural Network.